aclacinomycin has been researched along with Adenocarcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homma, T; Min, KY; Nakagawa, H; Yoneda, S; Yoshida, S | 1 |
| Fujii, M; Fujita, Y; Ishimitsu, T; Okabe, K; Toki, H | 1 |
| Hayakawa, O; Kudo, R; Takehara, M | 1 |
| Asbury, RF; Cnaan, A; Haller, DG; Harris, J; Johnson, L; Zaentz, SD | 1 |
| Anai, H; Kusumoto, H; Maehara, Y; Sugimachi, K; Takahashi, I; Yoshida, M | 1 |
| Anai, H; Kusumoto, H; Maehara, Y; Sugimachi, K | 1 |
1 trial(s) available for aclacinomycin and Adenocarcinoma
| Article | Year |
|---|---|
An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer.
Topics: Aclarubicin; Adenocarcinoma; Adjuvants, Immunologic; Antineoplastic Agents; Etoposide; Female; Humans; Male; Mitoxantrone; Organometallic Compounds; Pancreatic Neoplasms; Spiro Compounds; Survival Rate | 1994 |
5 other study(ies) available for aclacinomycin and Adenocarcinoma
| Article | Year |
|---|---|
[Aclacinomycin; benefits for the treatment of malignant pleural effusion].
Topics: Aclarubicin; Adenocarcinoma; Aged; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Pleural Effusion; Rabbits | 1983 |
[Efficacy of intrapleural treatment with aclacinomycin combined with closed tube thoracostomy for malignant pleural effusion].
Topics: Aclarubicin; Adenocarcinoma; Adult; Aged; Drainage; Female; Humans; Intubation; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Pleural Effusion; Thorax | 1984 |
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms | 1995 |
Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer.
Topics: Aclarubicin; Adenocarcinoma; Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Stomach Neoplasms | 1992 |
Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Fluorouracil; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Naphthacenes; Stomach Neoplasms; Succinate Dehydrogenase | 1987 |